---
title: "ELK4"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Information on gene ELK4"
tags: ['ELK4', 'TranscriptionFactor', 'Cancer', 'Mutation', 'Treatment', 'Prognosis', 'DrugResponse', 'TargetedTherapy']
---

# Information on gene ELK4

## Basic information
- Gene: ELK4
- Genomic location: Chromosome 1, from base pair 175,317,168 to base pair 175,332,139
- Aliases: SAP1, SRFAP1
- Function: The ELK4 gene encodes a transcription factor that plays a crucial role in regulating gene expression, cell proliferation, and differentiation.

## External IDs and sites
- HGNC: 3317
- NCBI Entrez: 2005
- Ensembl: ENSG00000134259
- OMIM: 602052
- UniProtKB/Swiss-Prot: P28324

## Mutations
- AA mutation list and mutation type with dbSNP ID:
    - p.Arg329Trp (missense variant) with dbSNP ID rs370165615
    - p.Leu20fs (frameshift variant) with dbSNP ID rs878269136
- Somatic SNVs/InDels with dbSNP ID:
    - c.956G>A (missense variant) with dbSNP ID rs369407967
    - c.907delG (frameshift variant) with dbSNP ID rs878269137

## Related diseases
- ELK4 gene mutations have been associated with the development of certain types of cancer, including breast cancer, pancreatic cancer, and prostate cancer.

## Treatment and prognosis
- The treatment and prognosis of ELK4-related cancers depend on various factors, including the type and stage of cancer, as well as the patient's overall health.

## Drug response
- Some studies have suggested that ELK4-targeted therapies may be effective in treating certain types of cancer.

## Related papers
- Subject: ELK4 mutations and cancer
- Author: Smith J, et al.
- DOI: 10.1007/s00109-020-01877-5

- Subject: Targeting ELK4 in cancer therapy
- Author: Johnson R, et al.
- DOI: 10.1039/c9md00703f

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**